Your search for lamictal returned 38 results

Lamotrigine 25mg, 50mg, 100mg, 200mg, 250mg, 300mg; ext-rel tabs.

Lamotrigine 25mg, 50mg, 100mg, and 200mg; orally-disintegrating tabs.

Lamotrigine 2mg, 5mg, 25mg; blackcurrant flavor.

Lamotrigine 25mg, 100mg, 150mg, 200mg; scored tabs.

Impax announced that the Food and Drug Administration (FDA) has approved Lamotrigine Orally Disintegrating Tablets, the generic version of GlaxoSmithKline’s Lamictal ODT.

The FDA has approved Actavis’ ANDA for Lamotrigine Orally-Disintegrating Tablets, a generic equivalent to GlaxoSmithKline’s Lamictal ODT.

Dr. Reddy’s has launched Lamotrigine Extended-Release Tablets, the generic version of GlaxoSmithKline’s Lamictal XR.

Wockhardt has received final approval from the FDA for marketing extended-release tablets of Lamotrigine, the generic version of GlaxoSmithKline’s Lamictal XR.

GlaxoSmithKline announced that the FDA has approved Lamictal XR (lamotrigine extended-release tablets) for conversion to monotherapy in patients ≥13 years with partial seizures taking one anti-epileptic drug.

The FDA has informed healthcare professionals and patients that Lamictal (lamotrigine, from GlaxoSmithKline) can cause aseptic meningitis.